Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
FDA
Mar 20, 2024, 14:34 |
Blog
Dive into the world of Precision Medicine this Myeloma and Colorectal Cancer Awareness Month - FDA Oncology
Quoting FDA Oncology on X: "Dive into the world of Precision Medicine this Myeloma and…
Mar 19, 2024, 16:03 |
Drugs
FDA granted accelerated approval to ponatinib with chemotherapy for adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
FDA Oncology Center of Excellence shared on X (Twitter): "On March 19, 2024, the Food…
Mar 19, 2024, 03:44 |
Drugs
Nitin Jain: The U.S. FDA approves lisocabtagene maraleucel for adults with relapsed or refractory CLL or SLL
Nitin Jain, The Director of the Leukemia CAR-T Program at the MD Anderson Cancer Center,…
Mar 18, 2024, 20:48 |
Blog
The FDA Commissioner’s blog on AI - FDA
Robert M. Califf, Commissioner at US Food and Drug Administration, shared a post by the FDA…
Mar 16, 2024, 15:53 |
Drugs
Blood Cancer Expert Dr. Mikkael Sekeres Endorses FDA Approval of New Drug, Imetelstat
Dr. Mikkael Sekeres is an expert in blood cancers at Sylvester Comprehensive Cancer Center - University of…
Mar 15, 2024, 18:07 |
Insight
Talazoparib in Combination With Enzalutamide for Prostate Cancer - FDA Oncology
FDA Oncology posted on X/Twitter: "FDA Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment…
Mar 10, 2024, 15:30 |
Blog
Lola Fashoyin-Aje: An amazing first week at the FDA Center for Biologics Evaluation and Research
Lola Fashoyin-Aje, Director, Office of Clinical Evaluation (Cell and Gene Therapies) at FDA, shared a post on…
Mar 8, 2024, 23:18 |
Blog
Nivo/Gem/Cis now FDA Oncology approved for 1L metastatic bladder cancer based on CM901 - Oncology Brothers
Oncology Brothers made the following post on X: “Nivo/Gem/Cis now FDA Oncology approved for 1L…
Mar 6, 2024, 11:34 |
Drugs
Rami Manochakian: U.S. FDA approves Amivantamab WITH CHEMOTHERAPY for 1st Line treatment of advanced non-small cell Lung Cancer with EGFR
Rami Manochakian, Hematology-Oncology Fellowship Director at Mayo Clinic, shared on X/Twitter: “HOT OFF THE PRESS…
Mar 4, 2024, 17:07 |
Drugs
George Mellgard: We delve into the complexities of FDA Accelerated Approvals in oncology using lessons from 16 withdrawn accelerated approvals in the past decade
George Mellgard, Medical Student at Columbia University Irving Medical Center in NYC, shared on X/Twitter:…
17
18
19
20
21
All:
938
Posts:
181 - 190
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube